Free Trial

This company has been marked as potentially delisted and may not be actively trading.

ETAO International (ETAO) Competitors

ETAO International logo

ETAO vs. HIMS, TDOC, AUNA, LFMD, SBC, TOI, AIRS, CCM, SHLT, and EVLO

Should you be buying ETAO International stock or one of its competitors? The main competitors of ETAO International include Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), LifeMD (LFMD), SBC Medical Group (SBC), Oncology Institute (TOI), AirSculpt Technologies (AIRS), Concord Medical Services (CCM), SHL Telemedicine (SHLT), and Evelo Biosciences (EVLO).

ETAO International vs.

Hims & Hers Health (NYSE:HIMS) and ETAO International (NASDAQ:ETAO) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

In the previous week, Hims & Hers Health had 33 more articles in the media than ETAO International. MarketBeat recorded 33 mentions for Hims & Hers Health and 0 mentions for ETAO International. Hims & Hers Health's average media sentiment score of 0.74 beat ETAO International's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Overall Sentiment
Hims & Hers Health Positive
ETAO International Neutral

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 0.2% of ETAO International shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 20.8% of ETAO International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Hims & Hers Health has a net margin of 8.19% compared to ETAO International's net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat ETAO International's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
ETAO International N/A N/A N/A

Hims & Hers Health currently has a consensus price target of $37.67, indicating a potential downside of 34.95%. Given ETAO International's higher probable upside, analysts plainly believe ETAO International is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
ETAO International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Hims & Hers Health has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500. Comparatively, ETAO International has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500.

Hims & Hers Health received 44 more outperform votes than ETAO International when rated by MarketBeat users.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
44
34.65%
Underperform Votes
83
65.35%
ETAO InternationalN/AN/A

Hims & Hers Health has higher revenue and earnings than ETAO International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.78B7.26-$23.55M$0.6983.92
ETAO International$58.89M0.00-$896.68MN/AN/A

Summary

Hims & Hers Health beats ETAO International on 11 of the 14 factors compared between the two stocks.

Get ETAO International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETAO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ETAO vs. The Competition

MetricETAO InternationalOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$2,000.00$1.78B$5.38B$8.39B
Dividend YieldN/AN/A5.21%4.10%
P/E RatioN/A29.9226.8019.71
Price / SalesN/A1.58389.55117.28
Price / CashN/A36.0138.2534.62
Price / BookN/A16.426.804.50
Net Income-$896.68M-$52.07M$3.23B$248.18M

ETAO International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ETAO
ETAO International
N/AN/AN/AN/A$2,000.00$58.89M0.003,600
HIMS
Hims & Hers Health
2.3602 of 5 stars
$58.54
-4.2%
$37.67
-35.7%
+229.9%$13.10B$1.78B133.05650Trending News
Insider Trade
High Trading Volume
TDOC
Teladoc Health
3.6814 of 5 stars
$7.28
-0.8%
$9.71
+33.4%
-40.9%$1.28B$2.55B-1.265,100Positive News
Analyst Revision
Gap Down
AUNA
Auna
3.672 of 5 stars
$6.97
+0.4%
$13.50
+93.7%
-22.3%$515.87M$4.39B18.3414,958Earnings Report
LFMD
LifeMD
1.2691 of 5 stars
$9.67
+1.2%
$11.00
+13.8%
+39.7%$439.48M$234.01M-15.11230Gap Down
High Trading Volume
SBC
SBC Medical Group
N/A$3.48
+3.6%
N/AN/A$360.57M$205.42M0.00N/ANews Coverage
Earnings Report
Analyst Revision
TOI
Oncology Institute
2.2438 of 5 stars
$3.04
+28.3%
$7.00
+130.3%
+348.0%$229.70M$393.41M-3.90660High Trading Volume
AIRS
AirSculpt Technologies
0.4226 of 5 stars
$3.55
+4.7%
$3.75
+5.6%
+0.5%$208.67M$172.10M-25.36240Gap Up
High Trading Volume
CCM
Concord Medical Services
0.6399 of 5 stars
$7.80
-4.9%
N/A+20.1%$33.87M$383.96M0.00970Analyst Forecast
SHLT
SHL Telemedicine
N/A$2.05
flat
N/AN/A$33.61M$55.94M0.00583
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$6,000.00N/A0.00120

Related Companies and Tools


This page (NASDAQ:ETAO) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners